Loading data for AVR — first visit, this takes a few seconds.
Anteris Technologies Global Corp. (AVR)
NasdaqGM: AVR
· 即時價格 · USD
9.04
+0.32 (3.67%)
收盤價： Sep 04, 2026, 8:00 PM
股價、關鍵數字和最新消息，都在這一頁。
Anteris Technologies Global Corp.（AVR）股價、分析與資料
無可用資料
| 買價 | 5.95 |
| 市值 | 881M |
| 營收 (ttm) | 2.24M |
| 淨利（ttm） | -104M |
| 0.00 | |
| -1.95 | |
| n/a | |
| -9.37 | |
| P/B (ttm) | 3.50 |
| P/S (ttm) | 392.49 |
| 財報日期 | Nov 12, 2026 |
| 賣價 | 10.57 |
| 成交量 | 362,900 |
| 20 日平均成交量 | 1,071,609 |
| 開盤價 | 8.66 |
| 前收盤價 | 8.72 |
| 當日區間 | 8.66 - 9.10 |
| 52 週範圍 | 3.30 - 11.05 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 AVR
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification prepa...
完整的公司簡介財報驚奇
Anteris Global 已於 Aug 11, 2026 公布季度財報：
- 營收為 $1.01M 低於預期 $0, 年增 63.27% 成長.
- 每股盈餘為 -0.3 低於預期 -0.09, 年增 50.82% 成長.
第 1 頁，共 2 頁